A minimally invasive, same-day procedure for chronic joint pain from osteoarthritis — knee, shoulder, and hip. No surgery, no general anesthesia, no joint replacement. Performed by a leading interventional radiologist at Mount Sinai.
Overview
Genicular artery embolization (GAE) is a minimally invasive, catheter-based procedure that treats chronic joint pain caused by osteoarthritis. It works by targeting the abnormal blood vessels — called neovascularization — that develop around arthritic joints and are directly responsible for driving persistent inflammation and pain signals.
In a healthy joint, blood vessel growth is regulated. In osteoarthritis, abnormal new vessels grow into the joint lining (synovium) alongside nerve fibers, amplifying pain. GAE uses microspheres delivered through a catheter to selectively block these abnormal vessels, reducing the inflammatory pain cycle without touching the joint itself.
The procedure is performed entirely through a small puncture — typically at the wrist or upper thigh — under mild sedation and real-time X-ray imaging guidance. There is no surgical incision, no general anesthesia, and no joint replacement required. Patients go home the same day and typically return to normal activities within a few days.
GAE does not cure osteoarthritis, but published clinical data consistently show significant, durable pain reduction lasting 12–24 months or longer in the majority of patients — making it an effective, non-surgical option for those seeking knee pain relief in New York without surgery or joint replacement.
Published studies show meaningful pain reduction in the majority of GAE patients at 12-month follow-up.
Patients go home the same day — no overnight hospital stay, no surgical wound.
GAE is performed as an outpatient procedure under mild sedation with rapid recovery.
Dr. Fischman performs GAE for osteoarthritis pain in the knee, shoulder, and hip.
Why Dr. Fischman
Dr. Fischman is one of the most experienced GAE operators in the United States, having performed hundreds of genicular artery embolization procedures across the knee, shoulder, and hip.
A prolific clinical researcher with over 130 peer-reviewed publications, Dr. Fischman's academic work spans embolization techniques, outcomes research, and minimally invasive innovation across interventional radiology.
Procedures are performed at Mount Sinai Health System — one of the nation's leading academic medical centers — with full imaging, anesthesia, and post-procedure support infrastructure.
As Program Director of IR Residency at Mount Sinai, Dr. Fischman trains the next generation of interventional radiologists and lectures internationally on embolization techniques including GAE.
Recognized as a Castle Connolly Top Doctor for 8 consecutive years — a distinction awarded based on peer nominations and reflecting sustained excellence in patient care and clinical outcomes.
Dr. Fischman regularly sees patients from across the United States and internationally. Initial consultations are available via telemedicine, and GAE is a same-day outpatient procedure — many patients travel to NYC and return home the next day.
Conditions Treated
The knee is the most commonly treated joint with GAE and where the largest body of clinical evidence exists. Knee osteoarthritis is one of the most common causes of chronic knee pain in adults over 50, and a leading driver of total knee replacement surgery in the United States. For patients in New York seeking a non-surgical knee pain treatment, GAE offers a meaningful alternative when conservative treatments — physical therapy, NSAIDs, cortisone injections — have failed to provide lasting relief.
Symptoms Addressed
Chronic shoulder pain from glenohumeral osteoarthritis can be significantly limiting, interfering with sleep, overhead activity, and daily function. When physical therapy, anti-inflammatory medications, and steroid injections fail to provide lasting relief, GAE offers a non-surgical alternative that targets the neovascular tissue driving ongoing pain and inflammation in the shoulder joint.
Symptoms Addressed
Hip osteoarthritis is a major cause of chronic groin and lateral hip pain and a leading driver of hip replacement surgery. GAE for the hip applies the same neovascular embolization principles to reduce the inflammatory pain cycle in patients who are not yet candidates for or wish to avoid total hip arthroplasty. Clinical experience with hip GAE is growing, building on the strong evidence base from knee GAE.
Symptoms Addressed
The Procedure
Dr. Fischman reviews your symptom history, prior imaging (X-rays and MRI), and treatment history to confirm you are a GAE candidate and plan the approach. Telemedicine consultations are available for out-of-state and international patients.
Under mild sedation and local anesthesia, a catheter is introduced through a small puncture. Using real-time fluoroscopic imaging and contrast dye, Dr. Fischman maps the abnormal neovascular supply to the affected joint with precision before embolization.
Microspheres are selectively delivered to the abnormal vessels driving joint inflammation. Healthy vessels and surrounding structures are preserved. The goal is targeted reduction of neovascular tissue — not elimination of all blood supply to the joint.
You recover briefly on-site and go home the same day. Most patients return to light activities right away. Initial mild soreness around the treated joint is normal and typically resolves within a week. Pain reduction is gradual over 4–8 weeks as inflammation subsides.
Recovery Timeline
GAE vs. Other Treatments
Patients with chronic joint pain from osteoarthritis typically progress through a treatment ladder — from medications and physical therapy, to injections, to surgery. GAE sits at a critical point on that ladder: after conservative measures have failed but before committing to joint replacement. It offers meaningful pain relief without the risks, recovery, or permanence of surgery.
| GAE Dr. Fischman · Mount Sinai |
Steroid Injection | Joint Replacement | |
|---|---|---|---|
| Surgical Incision | ✓ None | None | Major incision required |
| Anesthesia | ✓ Mild sedation only | Local only | General or spinal |
| Hospital Stay | ✓ Same-day discharge | In-office | 2–4 day inpatient stay |
| Recovery Time | ✓ 3–5 days | Immediate | 3–6 months |
| Duration of Relief | ✓ 12–24+ months | 4–12 weeks typically | Long-term (permanent) |
| Addresses Root Cause | ✓ Yes — neovascular tissue | Temporarily reduces inflammation | Replaces joint entirely |
| Repeatable | ✓ Yes if needed | Limited (3–4x/year max) | Revision possible but complex |
| Preserves Natural Joint | ✓ Yes | Yes | No — joint is replaced |
Individual outcomes vary. This comparison is for informational purposes only. Dr. Fischman will discuss your specific case and the most appropriate treatment options during your consultation.
Patient Selection
GAE may be appropriate for you if you meet one or more of the following criteria. Dr. Fischman evaluates each patient individually at Mount Sinai, reviewing imaging and clinical history before recommending any procedure.
Dr. Fischman's team will review your imaging, symptom history, and prior treatments to determine whether GAE is appropriate for you. Telemedicine consultations are available for patients outside New York and international patients.
Office: Mount Sinai Health System
5 East 98th Street, 12th Floor
New York, NY 10029
Phone: (212) 241-4046
Request a ConsultationInsurance
Insurance coverage for GAE is evolving. Some major plans cover GAE for knee osteoarthritis; others are still catching up. Dr. Fischman's team will perform a detailed insurance review and prior authorization assessment before your procedure so there are no surprises.
See It in Action
Dr. Fischman walks through genicular artery embolization — how the procedure works, what patients can expect, and why GAE offers a meaningful alternative to joint replacement for appropriately selected patients with osteoarthritis.
More videos available on @AaronFischmanMD on YouTube
Frequently Asked Questions
In osteoarthritic joints, abnormal new blood vessels (neovascularization) grow into the joint lining alongside nerve fibers. These vessels are directly responsible for amplifying pain signals — they are not present in healthy joints. GAE selectively blocks these abnormal vessels using microspheres delivered through a catheter. As the neovascular tissue resolves, the inflammatory pain cycle is disrupted, resulting in meaningful and durable pain reduction. Healthy blood supply to the joint is preserved.
Published clinical studies consistently report meaningful pain reduction lasting 12–24 months in the majority of GAE patients, with some patients maintaining benefit well beyond that. It is important to understand that GAE treats the pain-generating neovascular tissue — it does not halt the underlying arthritis progression. If symptoms return over time, the procedure can be repeated in appropriate candidates.
Yes. Prior steroid injections or PRP do not disqualify you from GAE — in fact, GAE is often most appropriate for patients whose injections provided only short-lived or inadequate relief. The mechanisms are different: injections reduce localized inflammation temporarily, while GAE targets the neovascular tissue responsible for sustained pain signaling. Dr. Fischman will review your full treatment history during consultation.
GAE can significantly reduce pain and improve function, potentially delaying the need for joint replacement for months to years. For some patients — particularly those who are not ideal surgical candidates due to age, weight, or health conditions — GAE may be a long-term management strategy rather than a bridge to surgery. However, because GAE addresses pain rather than the structural arthritis itself, joint replacement may eventually be required in patients with advanced disease. GAE does not compromise or preclude a future joint replacement if one becomes necessary.
GAE has a well-established safety profile in published literature. The most common side effects are transient — mild soreness or warmth around the treated joint lasting a few days. Because Dr. Fischman performs GAE under fluoroscopic imaging guidance with careful angiographic mapping before embolization, non-target embolization (accidental blockage of vessels not intended for treatment) is rare when performed by an experienced operator. As with any catheter-based procedure, there are small risks of access site bruising, contrast allergy, and infection, all of which are discussed in detail during your consultation.
Insurance coverage for GAE is evolving rapidly. Some major commercial insurance plans now cover GAE for knee osteoarthritis; others still classify it as investigational. Medicare coverage varies by region and clinical circumstances. Dr. Fischman's team at Mount Sinai will conduct a thorough insurance verification and prior authorization review for every patient before scheduling the procedure. Contact our office at (212) 241-4046 to begin the coverage assessment process.
Yes. Dr. Fischman welcomes patients from across the United States and internationally for GAE consultations and procedures. Initial consultations can be conducted via telemedicine, and the procedure itself is a same-day outpatient procedure — many out-of-state patients travel to New York City and return home the same day or the following morning. Our team coordinates closely with referring physicians and can assist with logistics for traveling patients.
Radiofrequency ablation (RFA) for joint pain works by destroying the sensory nerves that transmit pain signals from the joint — it is a nerve-blocking approach. GAE works upstream by reducing the abnormal neovascular tissue that amplifies those pain signals in the first place. RFA is performed by pain management specialists using needles placed near specific nerves; GAE is performed by interventional radiologists using a catheter through the vascular system. Both are non-surgical approaches, and some patients with inadequate response to RFA have benefited from GAE, and vice versa. Dr. Fischman will help determine which approach — or combination — is most appropriate for your specific case.
Dr. Fischman Also Treats
Many patients who come to Dr. Fischman for joint pain are also candidates for other embolization procedures. Explore what else he treats at Mount Sinai.
Men's Health
A minimally invasive, same-day procedure for benign prostatic hyperplasia (BPH) — no surgery, no general anesthesia, no sexual side effects. Performed through the wrist at Mount Sinai.
Learn about PAE →All Procedures
Dr. Fischman offers a full range of interventional radiology procedures at Mount Sinai — including varicocele embolization, kidney cancer ablation, and complex IVC filter removal.
View all services →Schedule a consultation with Dr. Fischman at Mount Sinai, New York City — in person or via telemedicine.